Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
OHSU Knight Cancer Institute
National Institutes of Health Clinical Center (CC)
Incyte Corporation
Merck Sharp & Dohme LLC
Toray Industries, Inc
NGM Biopharmaceuticals, Inc
Eli Lilly and Company
Eastern Cooperative Oncology Group
Northwestern University
Masonic Cancer Center, University of Minnesota
Altor BioScience
Dartmouth-Hitchcock Medical Center
University of Southampton